Menadione - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for menadione and what is the scope of freedom to operate?
Menadione
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for menadione.
Summary for menadione
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 159 |
| Clinical Trials: | 5 |
| Patent Applications: | 6,242 |
| DailyMed Link: | menadione at DailyMed |
Recent Clinical Trials for menadione
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Scotmann Pharmaceuticals | Phase 3 |
| University of Health Sciences Lahore | Phase 3 |
| Tanta University | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for menadione
US Patents and Regulatory Information for menadione
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | MENADIONE | menadione | TABLET;ORAL | 002139-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
